ZL-1102
Product Specifications
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
ZL-1102 is a humanized monoclonal antibody inhibitor targeting interleukin-17A (IL-17A) . SCH-900117 is being investigated for its potential use in the treatment of autoimmune diseases such as psoriasis and rheumatoid arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog